Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: An innovative patient-centred treatment
Publication Details
Vaidya, J. S.,
Bulsara, M.,
Baum, M.,
Tobias, J. S.,
&
on behalf of the TARGIT-A trial authors
(2021).
Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: An innovative patient-centred treatment.
British Journal of Cancer, 124, 1469-1474.
Abstract
In the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.
Keywords
comment, TARGIT-A trial, radiotherapy, breast cancer, lumpectomy, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT)
Link to Publisher Version (URL)
